Bismuth Subgallate
GET
/api/v1/drug/bismuth-subgallateMechanism of action
Sourced from openFDAMechanism-of-action class: Acid-Base Activity.
Indications
Sourced from openFDA- Use for eliminating or reducing odor from flatulence (gas) and stool (feces).
Dosage & administration
Sourced from openFDADirections Adults and children 12 years and over: 1 to 2 tablets up to four times daily. Do not exceed 8 tablets in 24 hours. Children under 12 years: ask a doctor.
Warnings & precautions
Sourced from openFDAIf pregnant or breast-feeding , ask a health professional before use. When using this product a temporary, but harmless, darkening of the stool and/or tongue may occur. In case of overdose, get medical help or contact a Poison Control Center right away. Keep out of reach of children.
FAERS reports
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
46 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
- 1Vomiting1328%
- 2Abdominal Pain1022%
- 3Dyspnoea1022%
- 4Abdominal Distension920%
- 5Blood Uric Acid Increased817%
- 6Nausea817%
- 7Constipation715%
- 8Drug Hypersensitivity715%
- 9Dry Mouth715%
- 10Fatigue715%
- 11Off Label Use715%
- 12Sleep Disorder715%
- 13Somnolence715%
- 14Stress715%
- 15Anaemia613%
Clinical trials
The 4 most recently updated of 4 ClinicalTrials.gov registrations naming Bismuth Subgallate as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- Real-world Performance and Safety of Cerviron® in the Treatment of VaginitisCompleted · Observational · 111 enrolled · Perfect Care DistributionNCT05652959updated 2023-04-19
- RWE Study in the Treatment of Cervical Lesions of Various EtiologyCompleted · Observational · 345 enrolled · Perfect Care DistributionNCT05668806updated 2022-12-30
- Dental Implants in Patients Under Oral Anticoagulant TherapyCompleted · Interventional · 71 enrolled · Jorge Ernesto AguilarNCT04846114updated 2022-10-12
- Clinical Trial of Anusol Ointment for Symptom Relief in Patients With HaemorrhoidsCompleted · Phase 3 · Interventional · 66 enrolled · Church & Dwight Company, Inc.NCT05157711updated 2022-08-15
Frequently asked questions
- How does Bismuth Subgallate work?
- Mechanism-of-action class: Acid-Base Activity.
- What is Bismuth Subgallate used for?
- According to FDA labeling, Bismuth Subgallate carries indications including: Use for eliminating or reducing odor from flatulence (gas) and stool (feces).. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
- What class of drug is Bismuth Subgallate?
- Bismuth Subgallate is classified as Acid-Base Activity, Digestive/GI System Activity Alteration.
- What are the brand names for Bismuth Subgallate?
- Bismuth Subgallate is marketed under brand names including Devrom.
Note. Data for
bismuth-subgallate is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.